AndhraNews.net
Home » Features » Companies » Biostar Pharmaceuticals

Biostar Pharmaceuticals


About Biostar Pharmaceuticals

Biostar Pharmaceuticals, Inc., (OTC Bulletin Board: BSPM) is a Xianyang-based developer, manufacturer and supplier of pharmaceutical products and medical nutrients addressing a variety of diseases and conditions. The Company's most popular product is its Xin Ao Xing Oleanolic Acid Capsule, an over-the-counter (OTC) medicine for chronic hepatitis B, a disease affecting approximately 10% of the Chinese population. In addition to its hepatitis product, Biostar manufactures two broad-based OTC products, two prescription-based pharmaceuticals and ten nutrients. The Company has adopted international standards and is in the process of applying for three patents.

Timeline

  • October 09: The company announced that the Chinese Military Drug Administration has granted clearance to begin clinical trials on the Company's new drug application, the Zushima Analgesic Aerosol Spray.
  • December 09: Announcement of the completion of the preparation to launch its flagship Xin Aoxing Oleanolic Acid ("Xin Aoxing") capsules for the treatment of Hepatitis B in Beijing and Shanghai in early January 2010.
  • January 2010: Announcement of a series of measures adopted to strengthen the Company's corporate governance in compliance with the listing requirements of a senior U.S. exchange.

Biostar Pharmaceuticals in News

Hampton Growth (HGR) Selected as a Sponsor of the 2011 Global Hunter Securities Conference in San Francisco
Hampton Growth (HGR), an innovative boutique investor relations and communications firm focusing on high-growth companies, today announced it was selected to be a sponsor of the 2011 Global Hunter Securities (GHS) Conference being held July 17-19, 2011, at the InterContinental Hotel in San Francisco.

Hampton Growth (HGR) to Sponsor DealFlow Media's IPO Conference 2011
Hampton Growth (HGR), an innovative boutique investor relations and communications firm focusing on high-growth companies, announced today that it was selected to be one of the sponsors of DealFlow Media's IPO Conference 2011 being held April 12th & 13th at The Grand Millennium in Beijing, China.

Hampton Growth (HGR) to Sponsor 2011 Rodman & Renshaw Annual China Investment Conference in Shanghai
Hampton Growth (HGR), an innovative boutique investor relations and communications firm focusing on high-growth companies, announced that it was selected to be one of the sponsors of the 2011 Rodman & Renshaw Annual China Investment Conference being held March 6th through March 8th, 2011, at Le Royal Meridien Shanghai Hotel in Shanghai, China.

Comment on this story

Share